Berti, Francesco
Romano, Maria Rosaria
Micoli, Francesca
Adamo, Roberto http://orcid.org/0000-0001-5228-6088
Article History
Received: 7 February 2021
Revised: 25 February 2021
Accepted: 28 February 2021
First Online: 27 April 2021
Declarations
:
: FB, MRR, FM and RA are employees of GSK group of companies and inventors in patent related to this topic. This work was undertaken at the request of and sponsored by GlaxoSmithKline Biologicals SA.<i>Menomune</i>, <i>Menactra</i> and <i>MenQuadfi</i> are trademarks of Sanofi Pasteur; <i>Mencevax</i>, <i>Menitorix</i>, <i>Menveo</i> and <i>Bexsero</i> are trademarks of GSK; <i>Meningtec</i> is a trademark of Nuron Biotech; <i>NeisVac-C</i>, <i>Nimenrix</i> and <i>Trumemba</i> are trademarks of Pfizer; <i>MenAfrivac</i> is a trademark of the Serum Institute of India. <i>VA-Mengoc-BC</i> is a trademark of Finley Institute.
: This article does not contain any studies with human participants or animals performed by any of the authors.